Cite
HARVARD Citation
Piazza, F. et al. (2022). Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study. Human vaccines & immunotherapeutics. 18 (1), pp. 1-10. [Online].